Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.

Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F.

Pediatrics. 2004 Nov;114(5):e634-41. Epub 2004 Oct 18.

PMID:
15492353
2.

Role of risperidone in children with autism spectrum disorder.

Chavez B, Chavez-Brown M, Rey JA.

Ann Pharmacother. 2006 May;40(5):909-16. Epub 2006 Mar 7. Review.

PMID:
16684811
3.

Pharmacotherapy of irritability in pervasive developmental disorders.

Stigler KA, McDougle CJ.

Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):739-52, vii-viii. doi: 10.1016/j.chc.2008.06.002. Review.

PMID:
18775367
4.

The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.

Posey DJ, McDougle CJ.

Harv Rev Psychiatry. 2000 Jul-Aug;8(2):45-63. Review.

PMID:
10902094
5.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
6.

Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.

Fowler JA, Bettinger TL, Argo TR.

Clin Ther. 2008 Feb;30(2):231-48. doi: 10.1016/j.clinthera.2008.02.011. Review.

PMID:
18343262
7.

A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders.

Simeon J, Milin R, Walker S.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Feb;26(2):267-75. Review.

PMID:
11817503
8.

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.

McDougle CJ, Scahill L, McCracken JT, Aman MG, Tierney E, Arnold LE, Freeman BJ, Martin A, McGough JJ, Cronin P, Posey DJ, Riddle MA, Ritz L, Swiezy NB, Vitiello B, Volkmar FR, Votolato NA, Walson P.

Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):201-24. Review.

PMID:
10674197
9.

Risperidone: a potential treatment for autism.

Posey DJ, McDougle CJ.

Curr Opin Investig Drugs. 2002 Aug;3(8):1212-6. Review.

PMID:
12211417
10.

Risperidone for the treatment of behavioral and psychological symptoms of dementia.

Tune LE.

J Clin Psychiatry. 2001;62 Suppl 21:29-32. Review.

PMID:
11584986
11.

Managing irritability and aggression in autism spectrum disorders in children and adolescents.

Robb AS.

Dev Disabil Res Rev. 2010;16(3):258-64. doi: 10.1002/ddrr.118. Review.

PMID:
20981764
12.

Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.

Aman MG, Gharabawi GM; Special Topic Advisory Panel on Transitioning to Risperidone Therapy in Patients With Mental Retardation and Developmental Disabilities.

J Clin Psychiatry. 2004 Sep;65(9):1197-210. Review.

PMID:
15367046
13.

Pharmacotherapy in children and adolescents with pervasive developmental disorders.

Scahill L, Koenig K.

J Child Adolesc Psychiatr Nurs. 1999 Jan-Mar;12(1):41-3. Review.

PMID:
10347430
14.

Off-label second generation antipsychotics for impulse regulation disorders: a review.

Scheltema Beduin A, de Haan L.

Psychopharmacol Bull. 2010;43(3):45-81. Review.

PMID:
21150846
15.

Aripiprazole for autism spectrum disorders (ASD).

Ching H, Pringsheim T.

Cochrane Database Syst Rev. 2012 May 16;(5):CD009043. doi: 10.1002/14651858.CD009043.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;(6):CD009043.

PMID:
22592735
16.

Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis.

Fung LK, Mahajan R, Nozzolillo A, Bernal P, Krasner A, Jo B, Coury D, Whitaker A, Veenstra-Vanderweele J, Hardan AY.

Pediatrics. 2016 Feb;137 Suppl 2:S124-35. doi: 10.1542/peds.2015-2851K. Review.

17.

Efficacy of risperidone in children with disruptive behavioural disorders.

Duhig MJ, Saha S, Scott JG.

J Paediatr Child Health. 2013 Jan;49(1):19-26. doi: 10.1111/j.1440-1754.2011.02200.x. Epub 2011 Nov 3. Review.

PMID:
22050179
18.

Pharmacotherapy to control behavioral symptoms in children with autism.

Doyle CA, McDougle CJ.

Expert Opin Pharmacother. 2012 Aug;13(11):1615-29. doi: 10.1517/14656566.2012.674110. Epub 2012 May 3. Review.

PMID:
22550944
19.
20.

[Pharmacological treatments in patients with pervasive developmental disorders: A review].

Béhérec L, Quilici G, Rosier A, Gerardin P, Campion D, Guillin O.

Encephale. 2014 Apr;40(2):188-96. doi: 10.1016/j.encep.2012.01.014. Epub 2013 Dec 23. Review. French.

PMID:
24369879

Supplemental Content

Support Center